Skip to main content

Want a detailed portfolio tracker?

Century Therapeutics (IPSC) P/E (2021 - 2026)

Century Therapeutics (IPSC) P/E from Jun 18, 2021 to Jul 21, 2026. The TTM Century Therapeutics (IPSC) P/E is -4.35. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Century Therapeutics (IPSC)

YearP/EChange
2026-4.35-81.73%
2025-23.80+1420.55%
2024-1.57-59.12%
2023-3.83-33.84%
2022-5.79-65.69%
2021-16.86N/A

Comparison Century Therapeutics (IPSC) P/E with competitors

Century Therapeutics (IPSC) P/E is -4.35.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.00-100.10%
ENLVEnlivex Ltd0.07-101.72%
FGENFibroGen Inc0.24-105.52%
CHRSCoherus Biosciences Inc0.85-119.51%
FBIOFortress Biotech Inc0.95-121.83%
ORMPOramed Pharmaceuticals Inc1.50-134.57%
AGENAgenus Inc3.01-169.21%
INVAInnoviva Inc3.15-172.54%
VXRTVaxart Inc3.55-181.64%
CRMDCorMedix Inc3.63-183.45%
CVACCureVac N.V.4.45-202.24%
GLPGGalapagos NV4.86-211.74%
SRPTSarepta Therapeutics Inc4.88-212.28%
ABEOAbeona Therapeutics Inc5.39-223.90%
ABUSArbutus Biopharma Corp5.60-228.69%
ZVRAZevra Therapeutics Inc5.89-235.39%
SPROSpero Therapeutics Inc6.23-243.24%
CGENCompugen Ltd6.31-245.21%
RIGLRigel Pharmaceuticals6.87-258.04%
SLXNSilexion Therapeutics Corp7.30-267.79%
OMEROmeros Corporation9.26-312.93%
AUPHAurinia Pharmaceuticals Inc9.58-320.43%
PLXProtalix BioTherapeutics Inc10.89-350.47%
ACADAcadia Pharmaceuticals Inc11.73-369.73%
TBPHTheravance Biopharma Inc12.26-382.00%
ADMAAdma Biologics Inc12.42-385.59%
HRMYHarmony Biosciences Holdings Inc13.82-417.84%
SABSSAB Biotherapeutics Inc14.14-425.10%
NAGENiagen Bioscience Inc14.82-440.79%
INCYIncyte Corp15.82-463.89%
REGNRegeneron Pharmaceuticals Inc15.86-464.67%
PBYIPuma Biotechnology Inc17.32-498.23%
CPRXCatalyst Pharmaceuticals Inc17.44-501.07%
EXELExelixis Inc17.54-503.34%
TGTXTG Therapeutics Inc18.97-536.18%
MDXGMimedx Group Inc20.55-572.67%
XOMAXOMA Royalty Corp22.87-626.08%
ARGXArgen X SE24.30-658.82%
CTMXCytomX Therapeutics Inc24.82-670.85%
XOMAOXOMA Royalty Corp25.34-682.89%
HALOHalozyme Therapeutics Inc25.62-689.31%
XOMAPXOMA Royalty Corp25.67-690.38%
VRTXVertex Pharmaceuticals Inc27.99-743.84%
RPRXRoyalty Pharma plc - Class A28.69-759.77%
SLNOSoleno Therapeutics Inc29.02-767.31%
ASNDAscendis Pharma A/S30.09-791.92%
LGNDLigand Pharmaceuticals Inc - Class B37.91-971.92%
APLSApellis Pharmaceuticals Inc39.02-997.43%
BMRNBiomarin Pharmaceutical Inc42.21-1070.81%
KRYSKrystal Biotech Inc45.34-1142.83%
ONCBeiGene Ltd69.54-1699.33%
PHARPharming Group N.V.75.03-1825.48%
TECHBio-Techne Corp101.96-2444.90%
VCELVericel Corp109.92-2628.03%
ALNYAlnylam Pharmaceuticals Inc117.96-2813.03%
GMABGenmab140.29-3326.48%
TLXTelix Pharmaceuticals Ltd162.15-3829.28%
CORTCorcept Therapeutics Inc212.86-4995.42%